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In vivo and in vitro studies have been done to determine the site of
biosynthesis and processing of styrene oxide (SO) induced epoxide hydro
lase (EH). Adult male Long—Evans rats were used to induce a form of
epoxide hydrolase using styrene oxide as the inducing agent. Rats were
administered 500 milligrams of SO per milliliter of corn oil intra
peritoneally per day. They were sacrificed forty—eight hours post—
injections and the livers were quickly removed, homogenized and frac
tionated on a sucrose discontinuous density gradient to obtain the micro
somal fraction. Epoxide Hydrolase was synthesized in a cell—free system
using a rabbit reticulocyte lysate system. EH50 was partially purified
using lubrol — WX detergent solubilization and ion exchange chromatography.
Analysis of EH50 using SDS—PAGE showed the in vivo synthesis of a microsomal
form of the enzyme. Autoradiography of the in vitro synthesis product
(EH5O) showed that the enzyme is processed on RER-niembrane bound polysomes.
The results suggest that EH50 is synthesized on membrane-bound polysomes
and follows the regulatory processing pathway of secretory proteins and,
putatively, integral membrane proteins.
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In today’s environment there are many pollutants in the soil,
waterways and atmosphere which are potential mutagens and/or carcinogens.
Many of these compounds exist as aromatic or olefinic compounds which
are biotransformed in mammals by enzymes localized in the endoplasmic
reticulum. Membrane—bound monooxygenases can catalyze these compounds
to epoxides and arene oxides, which in most cases are highly reactive
electrophiles and can be hydrated enzymatically via epoxide hydrolase.
Microsomal epoxide hydrolase (E.C.3.3.2.3) is a family of integral
membrane enzymes of the endoplasmic reticulum responsible for the meta
bolism of many endogenous and exogenous lipophilic compounds, some of
which may be mutageriic and/or carcinogenic (Conney, 1967, Miller and
Miller, 1981, Lorenz et al, 1984). Epoxide hydrolase converts epoxides
to dihydrodiols, which is a very important step in the detoxication j
of these compounds. However, many investigators have also shown that
epoxide hydrolase converts many of these compounds (the polycyclic aro
matic hydrocarbons are the most extensively studied) to more reactive
“bay region” diol epoxides (Pelkonen and Nebert, 1982) which are more
toxic than the parent structure. This phenomenom, (duality of function
in detoxication and toxication of some compounds) of epoxide hydrolase
has created great interest in understanding the role of xenobiotic
metabolizing enzymes in the cell.
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Presently, a large number of investigators have induced, isolated
and purified epoxide hydrolase from liver microsomes of man and a variety
of other mammals in order to evaluate its dual role in the cell’s de
fense mechanism. A great deal of information has been obtained concern
ing the enzyme’s role in the metabolism of compounds, however, an important
question not answered completely concerns the biosynthesis and mechanism
of insertion of this protein into the endoplasmic reticulum. Presumably,
during the biosynthesis of this membrane bound protein, cotranslational
modifications occur leaving an intact putative noncleavable amino terminal
signal sequence that remains in the mature protein during membrane inser
tion (Okada etal 1982, Ohisson etal 1981).
Epoxide hydrolase may follow the predictions of the “signal hypo
thesis,” which is the case in many secretory and putatively integral
membrane proteins. According to the “signal hypothesis,” proteins that
are secreted or destined for insertion into the endoplasmic reticulum
membrane in eukaryotic cells are synthesized as precursors with an extra
NH2 terminal sequence. This extra sequence consists mainly of 15-20
hydrophobic amino acids (Milstein et al, 1972; and Blobel and Dobbertstein,
1975a). The signal sequence initiates binding of the translational
complex to the endoplasmic reticulum, facilitating the passage of the
protein through a putative tunnel in the membrane as it is translated.
The destiny of the protein determines the fate of the signal sequence
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attached. If the protein is to be secreted (secretory and certain inte
gral membrane proteins), the signal sequence is removed from the growing
polypeptide during the transfer by a putative signal peptidase, giving
rise to the final product (authentic protein). This protein is localized
on the luminal surface of the endoplasmic reticulum prior to transloca—
tion (Blobel, 1980; Blobel and Dobberstein, 1975b). However, some
integral membrane proteins retain their signal sequences (Sabatini et
al, 1982). Many investigators have attempted to elucidate the functional
role of this sequence in determining the intracellular topography of
such proteins (Seidegard etal, 1982).
In our laboratory, we have investigated the in vivo and in vitro
aspects of the biogenesis of epoxide hydrolase in rat liver microsomes
following exposure to the direct acting carcinogen, styrene oxide. We
have assessed the cellular mechanisms of the biosynthesis of epoxide
hydrolase following 48 hr exposure to styrene oxide. We have determined
if the form of the enzyme identified follows the regulatory processing
pathway of previously reported integral membrane proteins (Blobel, 1980).
The results obtained provide a better understanding of the dual role of
epoxide hydrolase in cellular defense against a potential cancer-causing
agent. This, in turn, may provide a better understanding of the cellular
and biochemical mechanisms involved in toxicity, mutagenesis, and/or
carcinogenesis.
4
The purpose of this investigation was to determine the site of
biosynthesis and mechanism of insertion of one form of epoxide hydrolase
into the endomembrane system. Our goal was to provide supportive evidence
as to whether or not this enzyme follows the “signal hypothesis” for
insertion into the endoplasmic reticulum. Overall, this investigation
provides basic information on the induction, biosynthesis and mechanism
of insertion of a styrene oxide induced form of epoxide hydrolase and
the effects of this carcinogen on the cell’s protein synthesizing
machi nery.
Therefore the objectives of this research are as follows:
1. To isolate and partially purify epoxide hydrolase from
styrene oxide treated rat liver.
2.. To compare the changes in the protein concentration of the
smooth and rough microsomes of the styrene oxide treated
liver with untreated liver during the biosynthesis of epoxide
hydrolase.
3. To synthesize epoxide hydrolase in a cell-free system and




The literature discussed here covers the following aspects of the
enzyme, microsomal epoxide hydrolase: 1) its functional role in the
cell; 2) its purification and properties; 3) its distribution and
location; 4) its membrane topology; and 5) its regulation and
biosynthesis.
Functional Role in the Cell
Epoxide hydrolase (E.C.3.3.2.3.) is an enzyme found in a variety of
mammals, lower animal species (Walker et al, 1978, Walz et al 1983
Mertes et al, 1985) and some plants (Banthorpe and Osborne, 1984).
Epoxide hydrolase catalyzes the hydration of a wide range of reactive
epoxides to the corresponding trans—dihydrodiols. Epoxides are meta
bolically formed from many olefinic or aromatic moieties (Daly et al,
1972). Some of these epoxides are reactive electrophiles which can bind
covalently to cellular macromolecules and produce toxic, mutagenic and/or
carcinogenic effects. The enzymatic hydration of epoxides to less
chemically reactive trans—dihydrodiols by the enzyme epoxide hydrolase
has been recognized as a major mechanism of detoxication and cellular
defense (Jerina et al, 1968; Lu et a] 1975 and Oesch et al 1974).
However, several investigators (Hubermari et a] 1971, 1976; Wood et al
5
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1976; Kapitulnik ot al 1978; and Geacintov et al, 1984) have shown that
certain trans-dihydrodiols derived from some polycyclic aromatic hydro
carbons undergo further metabolism to reactive epoxides by the cytochrome
P—450 system. These highly reactive dihydrodiol epoxides may be ultimate
carcinogens. Gozurkara et al (1980) showed that these metabolites bind
covalently to DNA, in vivo and in vitro, in tissue culture, in isolated
rat liver and lung nuclei. They also bind to RNA and proteins. This
covalent binding can lead to cell death and mutations or transfor
mation to a cancer cell. The binding of chemical carcinogens or their
metabolically reactive products to DNA is believed to be essential in
chemical carcinogenesis (Miller and Miller 1981). Therefore, epoxide
hydrolase appears to play an important role in both toxication and detoxi—
cation in the cell (Guenther, 1981). In addition to its functional role
in the deactivation of xenobiotics, epoxide hydrolase also has an
endogeneous role in the cell.
Epoxide hydrolase is involved in the metabolism of steroids. In
1979, Bindel et al developed an assay to show that the enzyme responsi
ble for the hydration of xenobiotics also hydrated the steroid epoxide
16 , 17 epoxy, 1,3, 5, 10 estratrien 3—ol (estroxide) in rat liver.
Also, at that time they showed that testes microsomal fractions possessed
a epoxide hydrolase of high specific activity.
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This activity increases markedly during puberty. In 1982, the same
investigators showed that rat liver microsomal epoxide hydrolase catalyze
the hydrolysis of a steroid epoxide (androstine oxide) of the androgen
series. The properties of the reaction was compared to those of reaction
with a steroid epoxide of the estrogen series, estroxide, and two well
characterized xenobiotic substrates, benzo(a)pyrene—4,5,—Oxide and sty—
rene oxide. Watabe and Akamatsu (1974) demonstrated that epoxide hydro
lase plays a role in lipid peroxidation. The data indicated that lipid
peroxidation of microsomes plays an important role in regulating not
only the rate of epoxide formation from the olefin, but also the half
life of the epoxide formed in vitro.
Purification and Properties of the Enzyme
Oesch and Daly (1971) were the first to partially purify microsomal
epoxide hydrolase. The enzyme was isolated from guinea pig liver by
solubilization in cutscum followed by precipitation with ammonium sulfate
and desalting on a Sephadex G—25 column. A 14% yield, with a 40—fold
increase in specific activity, was obtained. This basic scheme for puri
fication with some modifications have been used by several investigators
(Oesch etal, 1974; Luetal, 1975, 1979; Levinetal, 1978; Griffin etal,
1978). However, a more rapid method of purification of the enzyme was
developed by Knowles and Burchell (1977). This procedure involves deter—
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gent solubilization (Lubrol—W X) and ion exchange chromatography. These
techniques are reported to give a 36% yield and 460—fold purity of the
enzyme. Kennedy and Burchell (1983) developed a single step method of
purification of microsomal epoxide hydrolase from crude solubulized
microsomes. They used monoclonal antibody to epoxide hydrolase coupled
to a cyanogen bromide activated Sepharose 4B affinity column to isolate
the enzyme.
The enzyme has been purified to apparent homogeneity as judged by
sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE),
isoelectric focusing, immunodiffusion, centrifugal sedimentation studies,
and its amino acid analysis. The physical characteristics and the
biochemical and molecular properties of the enzyme have been well
established.
The protein is quite hydrophobic in nature due to its membrane
location and its propensity for forming large aggregates in aqueous
solution. The purified enzyme(s) contains a single polypeptide of approxi
mately 49,000 daltons in the presence of SDS. Other molecular weights
of 48,000, 50,000, 53,000, 54,000, 57,000, 58,000 and 59,000 have been
reported (Oesch eta], 1984; Thomas eta], 1981; Guengerich etal, 1979).
In the absence of SDS, the enzyme aggregates into an oligomer with a
molecular weight of approximately 600,000 (Guengerich et a] 1979) which
corresponds to an S—value of 14.5, which does not migrate into polyacryla—
mide gels (Guengerich et aT 1979; Knowles and Burchell, 1977). The
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differences in molecular weights for epoxide hydrolase may be due to
isolation from different strains of animals (Graichen et al, 1984) or
due to multiple forms of the enzyme isolated (Guengerich et al, 1979).
Guenther etal (1980) purified cytosolic and microsomal epoxide hydrolase
from mouse and rat liver. Antibodies to the enzymes from the two species
were raised and tested. The results indicated that the two inicrosomal and
cytosolic forms of the enzyme are immunologically the same. However, no
cross reactivity was observed with the microsomal and cytosolic form
from the same animal species. Guengerich et al (1979) have shown that
various rat and human epoxide hydrolase(s) are immunochemically similar
enzymes. The antibody preparation showed high cross reactivity with
antigen from rat liver, lung, kidney and testis induced with 3—methyl—
cholanthrene, phenobarbital and trans-stilbene oxide with human epoxide
hydrolase.
Guengerich et al (1979) were the first of demonstrate that multiple
forms of epoxide hydrolase exist. Utilizing ion exchange chromatography,
peptide mapping, immunochernical studies, and amino acid composition they
demonstrated that untreated and phenobarbital (PB)—treated rats have dif
ferent forms of epoxide hydrolase from that of 3—methylcholanthrene (3—MC)
treated rats, trans—stilbene oxide (TSO) treated rats and from humans.
Lyman and Poland (1980) conducted crosses and backcrosses between C57BL/6J
and DBA/2J strains of mice to identify the epoxide hydrolase gene. The
results obtained showed genetic polymorphism of hepatic microsomal epoxide
hydrolase activity among inbred mouse strains. That is, the gene locus,
Ephi, codes for two allelic forms of microsomal epoxide hydrolase in
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mice. Levin et al (1983) demonstrated that a different form of epoxide
hydrolase was induced by cholestrol epoxide (referred to as “cholestrol—
induced epoxide hydrolase”) from that of the “xenobiotic induced” form
(phenobarbital, SKF—525A, g-chlordane, TSO, pregnonalone 16 a—carbon—
itrile, isosafrole and 2—acetylaminofluorene were used as inducers).
Enzymatic assays for epoxide hydrolase activity demonstrated that there
is no overlapping substrate specificity between the “cholestrol—induced
epoxide hydrolase” and the “xenobiotic-induced epoxide hydrolase.” Immuno—
precipitation studies also revealed that antibody raised to “xenobiotic
EH” was not reactive with the cholesterol 5,6, — oxide hydrolase. Guenther
and Oesch (1983) identified and characterized in C/57B46 mice a new
microsomal epoxide hydrolase (mEH2). They reported the enzyme catalyzes
the hydration of trans—disubstituted oxiranes such as trans-stilbene
oxide and trans—ethyl styrene oxide but not benzo(a)pyrene oxide, the
known substrate for the microsomal form previously reported (referred to
as mEH1). Antibody to mEH1 will not cross react with mEH2 and the pH
optima for the enzymes are different. A comparison between the new
inicrosomal form (mEH2) with the cytosolic form showed similarities in
substrate specificities and molecular weight (Guenther and Oesch, 1983).
Oesch et al 1984 isolated and purified a new form of microsomal epoxide
hydrolase from Spragrue—Dawley rats and New Zealand white rabbits. They
referred to the new form as cholesterol epoxide hydrolase (EHCH) because
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of its specificity for cholesterol 5,6 oxide, a trisubstituted epoxide.
The previous form (EHB, broad substrate specific) identified in their
laboratory did not hydrate this substrate. The two enzyme forms can
be discriminated by inhibitors, in that 5a ,imino-5—g—cholestane —
3B—ol potently inhibits EHCH but not EH8 while 1,1,1 trichloropropane
has the opposite specificity.
The pH optimum of the isolated enzyme(s) (depending on the substrate)
is between 7.4 and 9.4 (Oesch, 1974; Lu 1977; and Guengerich etal, 1979).
The enzyme is remarkably stable when purified to homogeneity (Bentley and
Oesch, 1975). It can be stored for weeks or months at 40C with less
than 10% loss of activity (Bentley and Oesch, 1975). The absorption
spectrum of the hom&jeneous protein has an extinction maximum at 280 nm
and a small, broad but significant absorption between 300 nm and 500 nm,
the latter in agreement with the faint yellow color of the enzyme solution.
An absorption at 290 nm is also observed, reflecting that epoxide hydrolase
contains a large amount of tryptophan (Bentley and Oesch, 1975).
Amino acid analysis indicates that the apparently homogeneous micro—
somal epoxide hydrolase contains relatively large amounts of tryptophan
and tyrosine and a high percentage of nonoplar residues (56%) (Lu etal,
1975 and Bentley et al, 1975). DuBois et al (1979) was the first to
sequence the amino acid residues of rat liver microsomal epoxide hydro—
lase at the N—terminal. They showed that methionine was the first amino
acid in the sequence. The C-terminal sequence was found to be valine—
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glutamine—alanine— OH. Bentley etal (1975) reported that the C-terminal
residue was either asparagine or a glutamine residue. DuBois etal (1982)
sequenced the human microsomal epoxide hydrolase and demonstrated that
the N—terminal sequence is identical to that of the rat. Heineman and
Ozols (1984) determined the complete amino acid sequence of hepatic
microsomal epoxide hydrolase (isolated from PB treated rabbit). Their
results showed that the protein contains 455 amino acid residues in a
single polypeptide chain and has a molecular weight of 52,691. A com
parison of the NH2 terminal of the rabbit form of the enzyme with the
human constitutive form shows that both have a hydrophobic sequence.
This hydrophobic sequence is functionally the same as the “signal sequence”
which is required for membrane insertion (Okada etal, 1982)
The purified enzyme can hydrate a variety of alkene oxides (such as
styrene—7,8 oxide and octene 1,2 oxide), as well as the K-region arene
oxides of phenanthrene, 7-methylbenzo(a)anthrene, 3 methylcholanthrene,
benzo(a)anthrene and the non—K—region arene oxides of napthalene and
benzo(a)pyrene (Guengerich et al, 1974; Lu et a], 1977; Bentley et al,
1976). Among the oxides tested, phenanthrene—9,1O oxide is the best
substrate, whereas dibenzo(a)(h)anthracene is the poorest.
The most sensitive and widely used assay procedure is a radiometric
method developed by Oesch eta] (1970) using (73-H) styrene oxide as the
substrate. Microsomes from rat, guinea pig and monkey were assayed and
found capable of catalyzing the conversion of styrene oxide to styrene
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glycol. A modification of this assay to a microassay to use as small as
10-20 mg biopsy specimen of human liver was developed by Oesch et al
(1974). Schmassman et al (1975) modified the microassay to a more rapid
procedure. Using the K—region epoxide of the potent carcinogen benzo(a)—
pyrene as a substrate, they succeeded in finding conditions in which the
unreacted substrate can be separated from the product by simple extrac
tion. In addition to the radiometric assays, spectrophotometric (Watabe
and Akatmsu, 1974; Hasegawa and Hammock 1982; Craven et al, 1982;
Westkaemper and Hanzlik, 1981), fluorometric (Dansette etal, 1979), high
performance liquid chromatographic (WestKaemper and Hanzlik, 1980) and
gas chromatographic assays (Westkaemper and Hanzlik, 1981) are used.
Distribution and Location
According to Walker et al (1978) liver microsomal epoxide hydrolase
activity is found in a wide variety •of vertebrate species. These studies
were carried out with hexachloro—6,7—epoxyl,4,4a,5,6,7,8,8a—octa hydra—
1, 4 methananapthaline (HEOM), benzo(a)pyrene—4,5 oxide and styrene 7,8
oxide as substrates. All three of these substrates are hydrated by micro—
somal epoxide hydrolase in all species investigated. Their results showed
that larger mammals have the highest activity for the enzyme and that
rodents, birds, amphibians and fish have less activity in the descending
order listed. Epoxide hydrolase is also found in other organisms.
Brooks (1973) showed that flies, roaches and beetles contain epoxicle
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hydrolase activity. Banthorpe and Osborne (1984) have isolated the enzyme
from plant tissue. The enzyme was found in extracts of both leaves of
Tanacetum vulgare (tanzy) and in callus cultures of Jasminum officinale—L.
Early studies done by Oeschetal (1970, 1971, 1974) established that
the enzyme is primarily found in the endoplasmic reticulum in close
association with the cytochrome P—450 system. Based on its universality
in the endoplasmic reticulum, Gill and Hammock (1980), Oesch (1974) and
Griffin and Gengozian (1984) have suggested the use of epoxide hydrolase
as a marker enzyme for the microsomal membrane and heptocarcinogenesis.
Investigations done by Mukhtar et al, (1979) Gontonvick and Bellward
(1981) and Pacifici et al (1984) have also demonstrated that epoxide
hydrolase is present in the cell nuclei, mitochondria and cytosol.
Other organelles that contain epoxide hydrolase activity are the golgi
and plasma membrane (Stasiecki, 1981).
The liver has been the main organ for isolation of epoxide hydrolase
and it contains the highest activity for the enzyme. However, Gill et
al (1979) and Lu et al (1980) have isolated the enzyme from the ovary,
lung and the kidney and showed that these organs contain activity for
epoxide hydrolase equal to that of the liver. Epoxide hydrolase is also
found in the tracheae, skin, and tongue (Oesch et al 1977; Bickers etal
1984) but in lower concentration than in the former organs mentioned.
More recently, Seidegard et al (1984) have demonstrated that the enzyme
is found in blood cells (leukocytes).
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Membrane Topology
Lu et al (1975) and Seidegard et al (1978, 1982) investigated the
lateral topology of epoxide hydrolase in the membrane of the endoplasmic
reticulum by subfractionation of microsomes. Separation into rough and
smooth microsomes revealed a slightly higher level of epoxide hydrolase
in the rough microsomes and that the enzyme is not randomly distributed
along the endoplasmic reticulum membrane. Studies done by Guengerich and
Davidson (1982) evaluated the interaction of microsomal epoxide hydrolase
and other proteins in situ in the membrane and concluded that micro—
somal epoxide hydrolase forms a complex with certain isozymes of cyto—
chrome P-450. Seidegard et al (1982) used 1251 in the presence of
lactoperoxidase to study the transverse topology of microsomal epoxide
hydrolase. The results suggest that 20—25% of the polypeptide is exposed
at the cytoplasmic surface of the endoplasmic reticulum and that the
enzyme is not exposed at all at the luminal surface.
Regulation and Biosynthesis
Hepatic epoxide hydrolase activity increases with maturation in
mammals and sex—linked differences in activity are seen (Oesch 1976;
Batt et al, 1984). During fetal development, epoxide hydrolase becomes
measurable only during the last four days before birth, steadily increas
ing thereafter. Enzymatic activity is barely measurable in livers of neo
natal rats while livers from adult male rats have from 2.5 to 3 times the
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specific activity found in the livers from adult females (Sharma et al,
1979; Hammock etal, 1983; Parkinson etal, 1983; Waechteretal, 1984).
Epoxide hydrolase activity may be elevated by induction. Oesch et
al (1971) found that epoxide hydrolase reaches maximal levels during
maturation of rats and that these levels can be increased by pretreatment
of animals with PB or 3-MC. Their data suggested that the induced enzyme
is substrate specific and that there is more than one epoxide hydrolase
in liver microsomes. Bucker et al (1979) showed that trans-stilbene
oxide (TSO) is a potent inducer of epoxide hydrolase in rat liver.
Animals received intraperitoneal injections of 2 moles per kilogram of
body weight of TSO on three consecutive days. Following the injections,
the rats showed a 3—fold increase in enzyme activity. Thomas et al
(1981) compared the ability of corn oil, pregnenoline 16-a—carbonitrile,
TSO, SKF-525A, g—chlordane, morphine, PB, 3—MC, Aroclor 1254 and isosafrole
to induce epoxide hydrolase in immature and mature rats. They found
that morphine, corn oil and SKF-525A have little or no effect on levels
or catalytic activity of the enzyme. Treatments with the other xenobiotics
produced significant increases in both enzyme concentration and catalytic
activity with the greatest induction by TSO. It was also observed that
the ratio of catalytic activity of the enzyme concentration is constant
despite the wide variation in epoxide hydrolase levels after treatment
with these xenobiotics. Seidegard and DePierre (1980) showed that benzil
is a potent activator of microsonial epoxide hydrolase in-vitro. Cells
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from liver of rats injected intraperitoneally with benzil were used in
this investigation. Their results showed a 9—fold increase in both the
apparent Vmax and Km of the enzyme. This activation was noncompetitive,
suggesting that the activator does not bind to the same substrate, styrene
oxide. Kuhiman etal (1981) showed that treatment of rats with N—nitro—
somorpholine (NNM) for seven weeks led to a focal increase in liver
microsomal epoxide hydrolase as early as two weeks after withdrawal of
the carcinogen. To see if these levels were reversible, livers were
examined at 2, 6, 12, 18 and 26 weeks after discontinuation of NNM feeding.
The elevation of epoxide hydrolase persisted throughout the entire obser
vation period and the focal increase was seen at very early stages in
hepatocarcinogenesis. The following stages, including benign hepatornas,
were high in enzyme activity but this activity was not observed in the
malignant tumors investigated. Astrom and DePierre (1981) observed that
the treatment of rats with 2-acetylaminofluorene (2—AAF) once daily for
five consecutive days increased the levels of epoxide hydrolase greater
than 7-fold even though 2—AAF is thought not to be metabolized by epoxide
hydrolase. It was also observed that TSO induction was more than 700%
of the control values.
Despite the recent advances in the purification and characterization
of rat liver epoxide hydrolase, only recently have any studies focused on
the capacity of mRNA to direct the synthesis of epoxide hydrolase in an
in vitro system. Gonzales and Kasper (1980) were the first to synthesize
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epoxide hydratase (hydrolase) in vitro in a rabbit reticulocyte lysate
translational system. Messenger RNA was isolated from membrane—bound poly
somes and free polysomes of phenobarbital treated rats to use in the cell—
free system. Their results showed that only mRNA isolated from membrane—
bound polysomes coded for the synthesis of epoxide hydrolase. The
molecular weight and partial proteolytic peptide patterns of the in vitro
synthesized EH was identical to that of the native enzymes indicating the
absence of a cleavable signal sequence. Pickett and Lu (1981) synthesized
epoxide hydrolase in a cell—free system and confirmed that mRNA isolated
from membrane-bound polysomes synthesized the enzyme. Their findings also
suggested that, unlike many secreted and some membrane proteins, epoxide
hydrolase appears not to requirea cleavable signal sequence for insertion
into the endoplasmic reticulum. Ohlsson etal (1981) used Xenopus laevis
(frog) embryo~ membranes to show the synthesis and insertion of epoxide
hydrolase in vivo and in vitro. Microinjection of rat liver RNA into
whole oocytes suggested that membrane insertion is neither cell—type nor
species specific because rat liver epoxide hydrolase can be inserted into
the endoplasmic reticulum of the frog oocyte membranes. The associ
ation is highly selective since, unlike albumin and at least 15 other
rat liver proteins, epoxide hydratase (hydrolase) is not secreted in
detectable amounts. Less than 5% of the epoxide hydrolase inside the
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oocyte is found in the medium. Okada et a] (1982) synthesized epoxide
hydrolase in a wheat germ extract cell-free system which was programmed
with poly(A)-containing mRNA extracted from free and membrane-bound
polysomes of rats pretreated with 3—methyicholanthrene. Epoxide hydrolase
mRNA was found only on bound polysomes and the product of its translation
in vitro had the same electrophoretic mobility as the mature protein,




In Vivo Isolation Of Epoxide Hydrolase
Induction Of Epoxide Hydrolase
Adult male (Long—Evans strain) rats weighing from 250 to 300 mg
were used. They were divided into two groups (five rats per group):
the control and the styrene oxide (SO) treated groups. Rats were
housed in a regular laboratory animal facility and fed a regular rat
chow pellet diet throughout the experiments. Both groups were treated
for 48- hr. They received intraperitoneal injections every 24 hr and
were fasted 24 hr prior to sacrifice. The control group received one
milliliter of pure corn oil (vehicle) and the SO treated group received
500 mg of styrene oxide (Aldrich Chemical Company) dissolved in one
milliliter of the vehicle. Forty—eight hours post—injection, both groups
were lightly anesthesized with ether and sacrificed by guillotining.
Isolation Of Smooth and Rough Microsomes and Free Poly
ribosomes Of Styrene Oxide Treated Rats
The rat livers were excised and quickly removed, blotted on asep
tic absorbent paper towels, weighed and cut into small pieces. The
tissue was placed in an ice cold (0—4°C) 0.25M homogenization buffer
(85% sucrose, 1M triethanolamine, 1M potassium chloride, 1M magnesium
chloride — referred to hereafter as STKM) in preparation for fraction—
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ation (Adelman et al, 1973). The tissue was homogenized with a Teflon
pestle-glass homogenizer, size C, rotating at 2000 xg. The homogenate
was centrifuged at 8000 xg for 5 mm at 0~C in a Beckman J2-21 model
centrifuge to obtain the post—nuclear supernatant (PNS). The PNS was
centrifuged at 12000 xg for 10 mm at 0~C in a Beckman J2-21 model
centifuge to obtain the post—mitochondrial supernatant (PMS). The PMS
was fractionated on a discontinuous sucrose density gradient to obtain
the smooth microsomes (SM), the rough microsomes (RM) and the free poly—
ribosomes (FP). The discontinuous step gradient contained concise regions
of 1.3M, 1.5M and 2.OM STKM. The overlayered PMS preparations were
centrifuged at 120,000 xg for 24 hr at 0°C in a Beckman L8—70 model
ultracentrifuge to sediment the aforementioned fractions. The SM, RM
and FP preparations were carefully removed from the gradient layers
and treated in the following manner. The FP fraction was immediately
resuspended in 1 ml of sterile distilled water and aliquoted into 20 ~il
amounts. The 20~il aliquots of the FP fractions were quickly frozen in
liquid nitrogen and stored at -80°C until ready for use in the in vitro
translation experiments. The remaining portion of the RM and the SM
fractions were carefully layered on cushion gradients consisting of 1.3M
and 2.OM STKM, respectively, and centrifuged at 120,000 xg at 0°C for 1
hr to reduce contamination with other membranes. The SM was carefully
removed from the cushion gradient and mixed with an equal volume 0.25M
STKM and centrifuged at 120,000 xg at 0°C for 1 hr to pellet the SM.
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The RM was also removed from the cushion gradient prior to pelleting and
was quickly frozen in liquid nitrogen and stored at —80°C for in vitro
translation experiments. Protein concentrations of each fraction were
determined spectrophotometrically at 280 nm and and the RNA concen
tration of the RM and FP was determined at 260 nm spectrophotometrically
(Fleck and Munro, 1962) in a Beckman DU—8 model spectrophotometer.
Spectrophotometric Assay For Epoxide Hydrolase Using Trans-Stilbene Oxide
As The Substrate
The spectrophotometric assay for epoxide hydrolase developed by
Hasegawa and Hammock (1981) was used to determine the enzymatic activity
of the styrene oxide induced form of epoxide hydrolase (EH50 ). All
ultraviolet spectra were performed at 37°C on a Beckman DU—8 model spectro—
photometer. All spectral measurements were made in O.2M potassium phos
phate (K2P04) buffer, pH 7.4. Epoxide hydrolase activity was assayed
in a final volume of 2 ml. The 2 ml incubation mixture consisted of.05—
2 mg of microsomal protein, .02M TSO, .04M KPO4, pH 7.4, and dH2O. The
buffer was equilibrated in the sample and reference cuvettes for 5 mm.
at 37°C. Ice—cold microsomal preparations (50—200,ug) from the styrene
oxide treated rats or the control rats were added to both cuvettes, and the
spectrophotometer was optically balanced. Forty microliters of 100%
ethanol was placed in the reference cuvette. The reaction was initiated
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by the addition of 40,ul of O.25M trans-stilbene oxide (TSO) in ethanol
with thorough mixing. The reaction was monitored at 229 nm at 30 sec
intervals for 5 mm.
Partial Purification of Microsomal Epoxide Hydrolase From Styrene Oxide
Treated Rat Liver
Microsomal epoxide hydrolase was partially purified using a niodi—
fication of the method of Knowles and Burchell (1977). All purification
steps were performed at 4°C. Smooth and rough microsomal pellets were
solubilized in 0.2MKPO4/1% lubrol buffer, pH 7.0 (buffer A). The
solubilized pellets were dialyzed overnight against 4 liters of 5mM
KPO4/O.05% lubrol buffer, pH 7.4 (buffer B). The dialysate was lyophi—
lized and resuspended in 0.5 ml of buffer B and applied to a 40cm X 2cm
DEAE cellulose column and eluted with buffer B. Collected fractions were
assayed for epoxide hydrolase activity. Fractions containing epoxide
hydrolase activity were pooled and dialyzed against 4 liters of 5mM
KPO4/0.05% lubrol buffer, pH 6.5 (buffer C). A 200 jul .aliquot of this
dialysate was quickly frozen in liquid nitrogen and stored at -80°C for
use in Concanavalin A—binding studies. The remaining volume of the
dialysate (31 ml) was lyophilized and resuspended in 0.5 ml of buffer C
and applied to a 20cm X 1.5cm Carboxymethyl (CM) cellulose column.
Fractions containing epoxide hydrolase activity were pooled and quickly
frozen in liquid nitrogen and stored at —80°C.
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Preparation of Proteins For SOS Polyacrylamide Gel Electrophoresis
Protein samples (20 to 50~il volumes) containing epoxide hydrolase
activity (7.5 to 25,ug of protein) were precipitated with ice cold 10%
trichloracetic acid (TCA) for 30 minutes at 4°C. The samples were
centrifuged at 18,000 xg for 2 minutes in a Eppendorf 5412 model micro—
fuge to pellet the protein. The pellet was resuspended in a gel loading
buffer (0.02% bromophenol blue, 200mM EDTA, 42.5% sucrose and 0.1M tris
base, [referred to hereafter as BEST soln], and 1.OM DTT and 20% SDS
[referred to as OS]) and sonicated with a Heat Systems sonicator model
220 at 20 decibles per mm for a total of 30 sec. The BEST-OS treated
samples were incubated in a 37°C water bath for 30 minutes for solubili—
zation. The solubilized samples were boiled for 2 mm, cooled to room
temperature and 10 jul of 0.25M indoacetimide was added. The samples
were re—incubated in a 37°C water bath for 20 mm and loaded on a
gel.
SDS—Polyacrylamide Gel Electrophoresis Analysis Of The Partially
Purified Styrene Oxide Induced Epoxide Hydrolase
Microsonial preparations and DEAE cellulose column and CM cellu
lose column eluates containing epoxide hydrolase activity were analyzed
on 7.5% sodium—dodecyl sulphate (SOS) polyacrylamide gels. The samples
(7.5 — 25 jug of protein) were prepared for electrophoresis according
to Laemmli (1970) and followed by alkylation using O.25M indoacetimide.
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Samples were electrophoresed for 17 hr at 60V and 1.5 milliamps per
slot in a discontinuous buffer system. The gels were stained and de
stained according to Laemmli (1970). The molecular weight of epoxide
hydrolase was determined by comparison of the measurement of its relative
mobility to the measurement of molecular weight standards relative mobi
lities in a SDS—polyacrylamide gel (Weber and Osborn, 1969).
Concanavalin —A— Sepharose Affinity Chromatography Analysis of Epoxide
Hydrolase
Concanavalin —A— sepharose affinity chromatography was performed to
determine if EH50 was glycoprotein. Procedures used were a modification
of the methods of Kennedy and Rosevear (1973). A 200jul volume (150,ig
of protein) of the dialysate from the DEAE cellulose column was applied
to 7cm X 0.7cm column containing concanavlin -A— sepharose beads equili
brated in a 5mM KPO4/0.05% lubrol buffer, pH 7.4. The unbound fractions
were eluted with the equilibration buffer. The column was washed 3X with
equilibration buffer. The bound fractions were eluted with the alpha—
methyl mannoside. Fractions were analyzed on a 7.5% SDS-polyacrylamide
gel.
Gel Double Immunodiffusion Analysis Of Epoxide Hydrolase
Rabbit anti—fish epoxide hydrolase [49000 dalton molecular weight]
was a gift from Nathan Jideama. Ouchterlony’s immunodiffusion technique
was done to test antigen antibody reactions (Ouchterlony, 1949). The
test medium consisted of 2% agarose made in 0.8% borate—buffered saline,
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pH 7.5 containing 0.01% merthiolate and 0.002% trypan blue. The test
medium was poured 5mm to a height in a 65mm X 15mm (25cm3) petri dish
and allowed to solidify at room temperature. Ten to twenty microliter
(25—50~4Jg) of epoxide hydrolase was placed in the outer wells and 20,iI
(50_Mg) of anti—serum to epoxide hydrolase was aliquoted into the center
well. The plates were incubated at 37°C in a moist chamber for 1—3 days.
They were monitored for the formation of antigen-antibody precipitin
lines every 24 hr.
RNA Extraction From Styrene Oxide Treated Rat Liver
Total liver RNA was isolated from styrene oxide treated rats 16 hr
post—injection. Extraction was done according to the methods of Sherrer
and Darnell (1962). Liquid nitrogen frozen liver was ground into a fine
powder which was mixed with extraction buffer (O.05M Tris, pH 7.5, O.005M
EDTA, pH 7.0, 0.15M NaCl, 5% SDS) consisting of an aqueous phase and
an organic phase: phenol: chloroform: isoamyl alcohol (50:50:1) and
blended in a Waring blender for 30—60 sec. The mixture was stirred for
10 mm, centrifuged at 3000 xg for 10 mm at 12°C. The total RNA was
precipitated at —20°C with 100% ethanol and 2.5M lithium chloride.
The final acquired RNA pellet was dissolved in 5 ml of sterile distilled
water. An 0.D. reading at 260 nm was done to determine the concentra
tion in A260 units (Fleck and Munro, 1962). The sample was aliquoted
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into 50,,ul volumes and quickly frozen in liquid nitrogen and stored at
-80°C. A RNA titration curve was done to determine the amount of RNA
most efficient in the synthesis of proteins in an in vitro rabbit reticul—
ocyte translational system.
In Vitro Isolation Of Epoxide Hydrolase
Cell Free Synthesis of Epoxide Hydrolase
Incorporation of [35S]—methionine into protein was performed in a
rabbit reticulocyte lysate cell—free translational system. In vitro
translation systems consisting of nuclease—treated rabbit reticulocyte
lysate and support reagents, programmed with total RNA or RER—MBP or
free polysomes were processed after the methods of Peiham and Jackson
(1976). Nascent polypeptides were synthesized ma 25 translation
mixture consisting of 12.5 jul of lysate (Promega Biotec Lot M116V),
3—5~ul of total RNA, 5 ,,ul of energy mix (O.1M ATP, O.02M GTP, O.6M
creatine phosphate (CP), 1mM 19 amino acids, [35S]—methionine E5.25
mCi/O.31], 1M KOH, 8 mg/mi creatine phosphokinase); 5 ul compensa
tion buffer (1M Tris—HC1, pH 7.4, 4M KC1, 1M MgCl2, distilled H20)
and O.~ii1 of distilled water. The reaction was incubated at 29°C for
59 mm.
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Co—Translational Insertion and Post—Translational Proteolysis of The
In Vitro Synthesized Products
Dog pancreatic microsomal membrane (DPM) was added co—translation—
ally to in vitro translation reactions that contained total RNA or free
polysomes. Trypsin (80 ,ug/ml) and chymotrypsin (80 jig/mi) were added
post—translationally to in vitro translation reactions that contained
total RNA, or RER—membrane—bound polysomes or free polysomes. Tryptic
digestion was carried out for 3 hr at 0°C. The digestion of the
translational products was stopped by the addition of 30 ,~ul trasylol
(protease inhibitor) to the translation mixture.
Assay for Incorporation Of [35S]—Methionine Into Proteins
To assess the incorporation of [35S]—methionine into nascent poly
peptides, 5 jil of the translation mixture was spotted onto a Whatman
3MM absorbant filter disc and the disc was placed into chilled 10%
trichloroacetic acid (TCA) for 10 mm. The filter disc was incubated
in 5% TCA at room temperature for 5 mm, followed by boiling in fresh 5%
TCA for 10 minutes. After TCA precipitation, the disc was saturated
with ethanol/ether, 50:50 (vol/vol) for 15 minutes, the ethanol/ether was
aspirated off the disc and the disc was placed in ethyl ether for 15
mm. Subsequently, the ethyl ether was aspirated off and the disc was
air dried and placed in 10 ml of scintillation fluid (New England
Nuclear liquifluor) and counted. Samples were counted in a Beckman
LS 7500 model scintillation counter at an efficiency of approximately
29% for 35S.
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Immunoprecipitation Of Epoxide Hydrolase From Translation Products
Epoxide hydrolase was immunoprecipitated from the in vitro
translation products according to the methods of Goldman and Blobel
(1978). The in vitro translation products (IVT) were preabsorbed to
a protein A—Sepharose ligand in situ. The supernatant was collected
and boiled for 2 nun in 2% SDS/trasylol. The mixture was diluted
four—fold with 1.25% triton—X buffer containing 1M tris—HCL (pH 7.4),
2M NaC1, O.2M EDTA and 20% triton X—100. Five microlitiers of mono—
specific rabbit anti—fish—epoxide hydrolase antiserum was added to the
sample. The sample was centrifuged at 8000xg for 30 seconds and
incubated for 1 hour at 370C. Twenty microliters of protein A—Sepharose
was added to the sample and was incubated for 1 hr at room temperature
(29°C) and for 12 hours at 4°C on a BBL tube rotator. The protein
A—Sepharose antigen-antibody complex was centrifuged at 8000 xg for 2
minutes. The sepharose beads were pelleted and washed four times in 1%
triton-X buffer. To the final pellet, 50,ul of 4% SDS was added and the
suspension was vortexed, boiled for 3 mm, cooled and centrifuged at
8000 xg for 2 mm. The sample radioactivity was determined by spotting
a ljil aliquot of the immunoprecipitate on a filter disc which was count
ed in 10 ml of toluene based scintillation fluid (aquafluor) in a Beckman
LS 7500 scintillation counter. The sample was analyzed for imunopre—
cipitable epoxide hydrolase by SDS—polyacrylamide gel electrophoresis.
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Autoradiography Of The Immunoprecipitable Epoxide Hydrolase
The SDS—polyacrylamide gels of the immunoprecipitated epoxide hydro—
lase (in vitro synthesized) were dried under vacuum overnight and exposed
to Kodax RP-X—O-Mat x—ray film for 72 hr at _800C using a Cronex intensi
fying screen. The film was developed in an automatic x—ray film proces
sor for visualization of synthesized (labeled) products (modified pro
cedures of Bonner and Laskey, 1974).
CHAPTER IV
RESULTS
Epoxide Hydrolase Induction Studies
Treatment of adult male rats with 1000 ml of styrene oxide for 48
hr caused a marked increase in the total protein concentration of the
endoplasmic reticulum (Table 1). The SO treated SM membrane total protein
concentration was 64% higher than the control SM membrane. The RM mem
brane protein concentration of the SO treated rats was 156% higher than
the control RM membrane protein concentration. Table 1 and Fig. 1 show
the marked differences in the proliferation of the endoplasmic reticulum
protein concentration of the SO treated rat liver. The SO treated frac
tions also showed an increase in epoxide hydrolase activity. The SO treat
ed microsomes (SM and RN) exhibited 20% increase (34.00 U/ml) in epoxide
hydrolase activity in comparison to the control microsomes (28.30 U/mi).
SDS—poiyacrylamide gel protein profiles also reveal an increase in the









SM 0.586 ÷ .008 0.685 + .001
RM 0.186 + .031 0.199 + .006
SO Treated
SM 0.971 ÷ .009 1.129 + .003
RM 0.430 ÷ .008 0.473 + .006
*Based on A280 protein assay standard curve using bovine serum albumin
as the standard.
Fig. 1. A graph showing the effects of styrene oxide on the induction
of protein in rat liver microsomes.
Marked increases in the protein concentration of SO
treated is observed. The percentage of microsornal protein
concentration induction is expressed as a percentage of


















































Fig. 2. SDS—polyacrylamide gel protein profiles of SO treated rat
liver microsomes showing the induction of epoxide hydrolase.
Samples were electrophoresed on 7.5% gels. Each lane
contains 25)Jg of protein.
Gel 1 — Smooth microsomes protein profile. Lane 1-molecular
weight protein standards; phosphorylase b, albumin, ovalbumin,
carbonic anhydrase, a—lactoalbumin; Lane 2 — control (untreat
ed) SM; Lane 3 — SO treated SM. Arrow indicates epoxide
hydrolase.
Gel 2 — Rough microsomes protein profiles, Lane 1 - control SM;
Lane 2 — SO treated RM. Arrow indicates epoxide hydrolase.
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Spectrophotometric Assay for Epoxide Hydrolase
The hydration of trans—stilbene oxide (TSO) by epoxide hydrolase
was measured by~f~H~wing -the~dec~ease_1-n a-bsor-ban-c-e----a-t---2-2-9-- -nm-.-- --A ---t-y-p-i-—
cal time course for the standard assay (50j~g of liver microsomal enzyme
solution, 0.25M TSO) is shown in Fig. 3. The decrease in absorbance was
linear for more than 5 mm. Hydration of TSO by epoxide hydrolase was
linear with protein samples in the range of 50,ug to 2001ug and with
time for at least 5 mm. Use of the boiled enzyme (30 mm at 100°C)
in the assay causes no hydration of TSO.
Partial Purification of Microsomal Epoxide Hydrolase (EH~0)
A styrene oxide induced form of rat liver microsomal epoxide hydro
lase partially purified by detergent (Lubrol-WX--Sigma Grade) solubili—
zation and ion exhange chromatography. The enzyme was purified 130 fold
from three whole rat livers. A 10% yield of EHs0 was obtained, exhibit
ing a specific activity of 382.10 units/mi of protein (see Table 2) as
determined by the method of Hasegawa and Hammock (1981). SDS—poiyacryl
amide gel analysis of the protein revealed a single polypeptide (Figs.
4,5, & 6). Comparison of EHso with protein standards of known molecular
weight showed the subunit molecular weight to be 56000 (Fig. 7).
Fig. 3. A graph showing enzymatic activity of microsomal epoxide -
hydrolase was linear with time.
Enzymatic hydration of trans-stilbene oxide was monitored
at 229 nm. TSO was incubated with 50,,ug of RM or SM from
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Fig. 4. SDS - PAGE protein profile of the isolation and partial
purification of EH50.
Samples were electrophoresed on a 7.5% gel.
This gel represents the isolation of the enzyme by sub—
cellular fractionation and detergent solubilization.
Lane 1 — molecular weight protein standards;
Lane 2 — PMS (251ug); Lane 3 — SM (251ug);
Lane 4 - RM (251ug); Lane 5 - Combined rnicrosomes
(2S~g); Lane 6 — Lubrol solubilized microsomes
(251ig); Lane7 — Combined DEAE eluates (25,ug).
Arrow indicates epoxide hydrolase.

Fig. 5. DEAE cellulose chromatography of solubilized microsomes
containing epoxide hydrolase activity.
Inset — SDS — PAGE of EH50
Lane 1 — DEAE eluted peak no. 2
profile; Lane 2 DEAE eluted peak no. 3.
Arrow indicates epoxide hydrolase protein band.
Chromatogram of DEAE eluted peaks with epoxide hydrolase


















10 20 30 40 50 60 70 80 90
FRACTION NUMBER
Table 2. Partial purification of SO induced rat liver epoxide hydrolase
Data based on the purification of EH50 from adult male rat livers.
Average body weight was 285 grams and the livers average weight
was 9.87 grams.
Total Protein Specific Relative Total
Purification Step (mg) *Activity Purification Activity Yield[%]
Cell Homogenate 1012.00 2.94 1 2975 100
PMS 340.00 8.64 3 2938 99
Crude Microsomes (SM and RM) 108.60 12.28 4 1337 45
Lubrol solubilized
Microsomal Pellets 52.00 28.40 9 1477 50
DEAE Cellulose eluates 10.00 120.37 41 1204 40
CM Cellulose eluates 0.80 382.10 130 306 10
*Specific activity = U/ml = mMoles/min x ml. It is calculated on the basis of the molar
































































Con A-Sepharose Affinity Chromatography of EHç0
SOS—polyacrylamide gel analysis of the unbound and bound eluates
acquired from samples passed through Con A columns revealed that EH50 is
not glycosylated. EHso was eluted in the unbound fraction indicating
that it did not bind to the Con—A—sepharose column which is specific
for glycoproteins (see Fig. 8).
Gel Inimunidiffusion of EH~0
Antibody raised to homogeneous fish liver microsomal epoxide hydro—
lase was used to identify EFfs0 activity in the crude microsomal frac
tions and the purified enzyme. Single immunoprecipitin lines were
observed in all fractions that contained microsomal EH50 activity (see
Fig. 9a). To ascertain that the antiserum was specific for the microsomal
form of enzyme isolated, a crude cytosolic preparation was also used in
the analysis. Figure 9b shows no immunoprecipitin line was observed in
the cytosolic fraction.
Titration of mRNA in an In Vitro Translation System Using Rabbit Reticu—
locyte Lysate
Titration of free and membrane—bound polysome preparations and
total RNA was initially done to determine the amount of the RNA in the
system which is most efficient in the translation of proteins. The
incorporation of [35S—] methionine into proteins was monitored for 5
minutes in the Beckman LS 7500 scintillation counter spectrophotonieter.
Figure 10 summarizes the results obtained. The titration of FP show
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that 3_jul aliquot of FP preparation, which corresponds to 15.65,ug/rni of
mRNA, is most efficient in the synthesis of proteins in the system used
and that RER—MBP and total RNA exhibit the highest efficiency at 4 ,ul
aliquots, which corresponds to 4.ljug/ml of mRNA and 38.50_Mg/mi of inRNA,
respecti vely.
In Vitro Synthesis of EHç0
In vitro translation of proteins in a cell—free rabbit reticulocyte
lysate system was achieved by utilizing total RNA, or free or membrane—
bound polysomal preparations isolated from styrene oxide treated rat
liver. Table 3 shows the amount of incorporation of [35S]—methionine
into proteins in a 25,ul translation mixture. Total [35SJ-methionine in
corporation in 25~il samples was 1.53 x ~ counts/mm in FP and 1.16 x
~ counts/mm in extracted total RNA. The cotranslational addition of
exogenous membrane (DPM) appeared to cause inhibition in the translational
system incorporation of [35S]—methionine into proteins. The addition of
5jul of DPM to the 25p1 samples produced 1.66 x ~ counts/mm in FP and
1.05 x i0~ counts/mm in extracted total RNA.
Immunoprecipitation of EHç~
SDS—polyacrylamide gel electrophoresis and autoradiography reveals
that epoxide hydrolase was immunoprecipitated from translation mixtures
that were programmed with total RNA, free or membrane bound polysome
preparations. (Table 3 and Figs. 11 and 12). The immunoprecipitable
epoxide hydrolase has a molecular weight of 56,000 daltons.
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Co—translational Processing and Post—translational Proteolysis of the
In Vitro Synthesized EH~0
The addition of stripped dog pancreatic microsomal membrane (DPM)
to in vitro translation mixtures programmed with free polysomes was
done to determine if the immunoprecipitable EH50 was a precursor of the
MBP form (Fig. 11, lane 2). The results showed no difference in the FP
preparation plus DPM iminunoprecipitable EH50. The protein immunopreci—
pitated has a molecular weight of 56,000 daltons. The total RNA prepa
ration was also used as a probe with the addition of DPM in hopes of
finding a difference once the protein was processed (inserted into the
membrane). The results also yield a 56000 daltons protein (Fig. 12 lane
2).
To test whether the DPM was functional, an IVT was done which
contained MBP, FP—DPM or FP+DPM. The translational products were di
gested posttranslationally and analyzed. Results indicated that the DPM
was in fact functional because the IVT products of the FP+DPM preparation
was protected from proteolysis whereby the FP-DPM preparation was digest
ed (Fig. 13). Immunoprecipitable EHs0 from MBP, FP+DPM or FP—DPM
translation mixtures were also proteolytically digested post-translation—
ally and the results also show that the “FP+OPM” was protected (Fig. 14).
Thus, these results suggest that the FP preparation contain de
tached RER polysomes.
Fig. 8. Protein profiles of the eluates from Con-A Sepharose
affinity chromatography of EH50.
Gel 1 - shows the profile of fraction applied to column.
Lane 1 — molecular weight standards;
Lane 2 - protein profile of sample;
(DEAE eluate) before application to Con - A column.
Gel 2 - shows the profile of fractions eluted from Con
A—column:
Lane 1 — molecular weight standards;
Lane 2 — unbound fraction eluate;
Lane 3 — bound fraction eluate.

Fig. 9. Ouchterlony immunodiffusion analysis of epoxide hydrolase
Ouchterlony plates were prepared in 2% agarose gels. Center
wells contain 201ug of antiserum to EH. Plate a: Well 1-
Solubilized microsomes (50,pg); well 2—SM (50 ug);
Well 3 — RM (501ug); Well 4—PMS (50,ug); Well 5 — CM eluted
EH50; (1Oj.ig) Well 6 - DEAE eluates that contain EH50.
Plate b: Well 1 — borate — buffered saline; well 2 - cyto—
sol fraction; Well 3 — empty; Well 4 — EH50 (10~g);


































































































Table 3. Incorporation of [35S]—methionine in an in vitro translation
system using a rabbit reticulocyte lysate system.
mRNA Total [35S]-methionine Immuno—
Source Incorporation Into Precipitable





RNA (Total) 115630 1057
RNA (Total) + DPM 105367 1296
Digested Lysate 87521
Fig. 11. Autoradiogram of SOS — gel showing immunoprecipitable EH50
from IVT products.
The system was programmed with RNA derived from RER-MBP or
FP: Lane 1 — RER—MBP EH50; Lane 2 — FP ÷ DPM EHso;
Lane 3 — FP — DPM EH50.
Arrow indicates the immunoprecipitated EHs0.

Fig. 12. Autoradiogram of SDS—gel showing immunoprecipitable EN50
from IVT products using extracted total RNA.
Lane 1 represents total RNA EN50; Lane 2 represents total
RNA E1-1~o in the presence of DPM.
Arrow indicates the immunoprecipitated EN50.

Fig. 13. Autoradiogram of SDS—gel of the IVT products following co—
translational and post—translational proteolysis.
Lane 1- Molecular weight standards;
Lane 2 — RM—MBP translated products;
Lane 3 — FP — DPM translated products.
Lane 4 — FP + DPM translated products

Fig. 14. Autoradiogram of SDS—gel of immunoprecipitable EH50
following cotranslational processing and posttranslational
proteolysi 5.
Lane 1 - FP — DPM; Lane 2 - RER—MBP;
Lane 3 — FP + DPM.
Arrow indicates the ininiunopreicipitated EH50.
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Comparison of the In Vivo EH~ with the In Vitro EH~~
The partially purified EHs0 was eluted from CM cellulose column
electrophoresed on the same gel with the immunoprecipitable EH~0 from
in vitro translation products. Results indicated the authentic (in vivo)
form comigrates with the in vitro form (Fig. 15). In vivo and in vitro
EHs0 have a molecular weight of 56000 daltons.
Fig. 15. SDS — PAGE comparison of the in vivo and in vitro EHs0
Lane 1 - Radioactive molecular weight markers; Lane 2 - SDS—
PAGE of pure EH50; Lane 3 - autoradiogram of in vitro synthe





Epoxide hydrolase is an enzyme which plays a very important role
in the metabolism of drugs, mutagens and/or carcinogens in a number of
naturally occurring, as well as synthetic compounds (Oesch et al, 1971;
Thomas et al, 1981; Seidegard and DePierre, 1983; Kuhlman et al, 1981).
Several investigators have demonstrated that phenobarbital (Gonzales
and Kasper 1980; Pickett and Lu, 1981) and 3—methylcholanthrene (Okada
et al, 1982; Guengerich et al, 1979) cause induction of mRNA programmed
for the synthesis of epoxide hydrolase. The induction of synthesis of
epoxide hydrolase has played a major role in understanding the complex
cascade of reactions involved in the metabolism of xenobiotics and the
functional site of the enzyme. Simultaneously, these investigators have
definitively shown that PB and 3-MC induced epoxide hydrolase is synthe—
sized on membrane bound polysomes of the rough endoplasmic reticulum.
Both of these chemicals under go the same fate in the cell. Phenobarbi—
tal and 3—methylcholanthrene are procarcinogens. They are first acti
vated by cytochrome P—450 to their reactive products prior to causing
induced synthesis of epoxide hydrolase. However, many chemicals are
direct acting carcinogens (Hemminki, 1983) and exist as highly reactive
products in the cell. Those highly reactive compounds also cause changes
in the levels of enzymes responsible for their metabolism. The induced
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synthesis of epoxide hydrolase after exposure of laboratory animals to
direct acting carcinogens have not yet been reported.
The investigation conducted in this laboratory has focused on under
standing the role of styrene oxide, a direct acting carcinogen, in the
induction of epoxide hydrolase. Styrene oxide induced the synthesis of
a form of epoxide hydrolase (EH50) in rat liver microsomes in vivo and
also in vitro in a rabbit reticulocyte lysate cell-free system using
RER—MBP, FP and total RNA from SO exposed liver. Subcellular fraction
ation of SO treated livers on a discontinuous sucrose gradient provided
the source for the translational machinery (ribosomes) needed in the in
vitro synthesis of Eli50. In vitro translations using polysomes attached
to membranes (RER—MBP) have been shown to synthesize EHs0. These
results initially suggested the existence of two different forms of the
enzyme of the same molecular weight. Both membrane—bound polysomes
and free polysomes directed the synthesis of a 56K polypeptide. Strip
ped DPM was cotranslationally added to the FP and resulted in the process
ing of two forms of the polypeptide, with the same molecular weight.
That is, the RER—MBP, FP — DPM and FP +DPM all synthesized a 56K poly—
peptide. However, further results using free polysomes in the presence
of the exogenous ribosomally stripped dog pancreatic microsomal membrane
(DPM) synthesized a 56K protein which was not susceptible to proteolytic
digestion (posttranslationally). Free polysomes devoid of microsomal
membrane (DPM) were subjected to posttranslational proteolysis and
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was not protected. This set of data provide conclusive evidence that
the free polysomal preparations do not consist entirely of free poly—
somes and strongly suggest that the FP contain detached RER-MBP, which
are capable of inserting into membranes. Detachment of ribosomes from
the RER is one of the most conspicuous ultrastructural alterations ob
served during hepatocarcinogenesis induced by a number of chemical car
cinogens (Svoboda and Higginson 1968; Fox et al, 1984). This situation
may explain why styrene oxide induced epoxide hydrolase (EH50) appears =
to be synthesized on FP but in fact, this may not be the case, since SO
may cause detachment of ribosomes from the RER.
The preceeding observations demonstrate that perturbed and detached
membrane—bound polysomes from the livers of SO treated rats are still
capable of synthesizing epoxide hydrolase in a cell-free systeme. These
findings are in agreement with studies from other laboratories (Okada
etal 1982; Gonzales and Kasper, 1984; Pickett and Lu, 1981).
Partial purification of SO induced epoxide hydrolase has been
achieved by detergent solubilization and ion exchange chromatography.
The protein is homogeneous as judged by SOS polyacrylamide gel electro—
phoresis and has a molecular weight of 56,000 daltons. Isolation of
EHs0 from endomembranes begs the question as to what is involved in its
processing. For example, is it glycosylated? To answer this question,
the ability of EH50 to bind specifically to a Con -A sepharoseaffinity
column was tested. Con A is a plant lectin which binds mannose residues
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present in oligosaccharides. Binding is specifically prevented by compe
tition with a—methyl inannoside. The results obtained by the Con A
affinity column binding studies showed that EH50 is not a glycoprotein
since it was eluted from the column in the nonbinding fraction.
The ability of the enzyme to hydrate two distinct substrates suggests
that it is a different form of the enzyme not previously reported. How
ever, this must be validated by its amino acid sequence analysis, which is
proposed as a project to be undertaken in this laboratory. Immunologi
cally, this enzyme has been shown to be cross reactive with rabbit
anti—fish—epoxide hydrolase (isolated in our laboratory) (Jideama and
Browne, 1985).
The enzyme synthesized in vitro comigrated on an SOS polyacryla—
mide gel with the purified native polypeptide (in vivo). Comigration
of the in vitro product with the authentic (in vivo) form suggest that
the enzyme has a noncleavable signal sequence. These data are also in
agreement with previous investigators (Ohlsson et al, 1981; Okada et al
1982). In addition to the presence of a noncleavable sequence, the post
translational proteolysis of this form of epoxide hydrolase (EH50)
suggest that the enzyme is deeply embedded in the membrane with no
portion of it cytoplasmically exposed.
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Sabatini et al (1982) suggested that signals for cotranslational
insertion of membrane polypeptides need not always be transient and
therefore, may remain in the mature protein. The data in our studies
suggest that the amino terminal sequence of the primary translation
product of EHso is not removed. The EH50 synthesized in vitro using total
RNA in the absence of added microsomal membranes was found to correspond
to that of the mature product. This suggests, since EH is a putative
endomembrane protein, corroborative support for the hypothesis
advanced by Sabatini etal (1982).
Heineman and Ozols (1984) have shown that the amino terminal seg
ments of epoxide hydrolase is rich in hydrophobic amino acids and resem
bles the signal sequences present in pre—secretory proteins. It is
suggested that these sequences function as signals for cotranslational
insertion. Sabatini et a] (1982) reported that if the amino terminal is
the putative cotranslational “insertion signal” of epoxide hydrolase
then one might have expected, by analogy with secretory proteins, that
most of the molecule would pass through the membrane leaving only a
segment of the C-terminal portion attached to it on the cytoplasmic side
by the permanent insertion segments. A priori, it is important to point
out that a portion of the epoxide hydrolase molecule is known to be
exposed on the cytoplasmic side (Seidegard et al 1983) of the microsomal
membrane, suggesting that this polypeptide also contains a “halt transfer”
signal that interrupts cotranslational transfer through the membrane
leaving a portion of the molecule on the cytoplasmic surface.
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Unlike, the models proposed by Sabatini et al, (1982) we have pro
posed a hypothetical model (Fig. 16) to describe the role of the amino
terminal cotranslational insertion signal of EH. The model shows the
insertion of the integral membrane protein EHso into the endoplasmic
reticulum. The model suggests that EH50 has putative “membrane stay
sequences.” We are suggesting that the presence of these sequences
prevents the vectoring of the nascent polypeptide through the endomem—
brane system. We believe that the protein is processed to its authentic
form as it is inserted into the endoplasmic reticulum. The model also
suggest that the protein is not exposed at the cytoplasmic surface of












Summarily, the data reported in this study show that:
1. Styrene oxide is an inducer of microsomal epoxide hydrolase in
rat liver;
2. Partial purification and enzymatic activity suggest that SO
induces a form of epoxide hydrolase in rat liver microsomes;
This form of microsomal epoxide hydrolase is inducible with 500
mg of styrene oxide in adult male Long—Evans rats within 48 hr
post—i ntraperitoneal injection;
This form of epoxide hydrolase is electrophoretically resolvable
on a 7.5% SDS—polyacrylamide gel and has a relative molecular
weight of 56,200;
3. In vivo and in vitro synthesis of EH50 suggest that it is
synthesized on membrane bound polysomes and has a noncleavable
signal sequence;
4. Concanavalin A binding studies suggest that EH50 is not a glyco—
protein;
5. This form of epoxide hydrolase is immunologically similar to fish




We have determined from the experimentally derived data delineated
above that the sites of biosynthesis of styrene oxide—induced epoxide
hydrolase are the ribosomes attached to the “rough” endoplasmic reticuli.
Moreover, the putative mode of insertion appears to be by the presence
of a noncleavable amino—acid sequence. This is inferred from the experi
mental results showing no molecular weight differences in the “pre-pro—
tein” synthesized in vitro, in the absence of dog pancreas microsomal or
in its presence. That is to say, the “preprotein” molecular weight moeity
is the same as that of the authentic form. The pertubation and detach
ment of membrane—bound polysomes by exposure to styrene oxide, a known
carcinogen, though not surprising, was unexpected and afforded some
pertinent resulting data. Ribosomes which appear to be “free” and
considered to routinely synthesize cytoplasmic proteins are not always
functionally the same. The presence or absence of a putative messenger
RNA containing a “signal sequence” for directing translation of a poly—
peptide in association with a microsomal membrane, if present, appears
to be the more definitive vector.
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into the endoplasmic reticulum membrane. Protein has
putative “membrane stay sequence.”
